Tumor collagenase-stimulating factor and tumor autocrine motility factor as tumor markers in bladder cancer--an update.
We have studied the role of combined measurements of tumor collagenase-stimulating factor (TCSF) and tumor autocrine motility factor (TAMF) in 83 first morning voids and 24-hour specimens in patients with bladder and renal cancer and control subjects. TCSF and TAMF were measured by immunoabsorption assay and motility test utilizing modified Boyden chamber. The mean concentrations of urinary TCSF and TAMF from cancer patients (n = 32) were 4- to 5-fold higher than those from benign conditions (n = 70). We compared TCSF and TAMF utilizing motility test in first morning voids (n = 18) and 24-hour urinary samples (n = 19). TCSF and TAMF were almost identical in terms of eluted proteins from morning voids and 24-hour urine samples. Invasive bladder cancer (n = 12) showed a significantly higher correlation (r = 0.9 and p = 0.0001) between motility response and urinary concentration of TCSF and TAMF. We have also localized these two glycoproteins in cell membranes and cytoplasms of cancer cell.
Javadpour
N
N
University of Maryland, Baltimore 21201.
Guirguis
R
R
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D051926:Basigin; D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000737:chemistry / Q000473:pathology / Q000652:urine*; D002295:Carcinoma, Transitional Cell / Q000737:chemistry / Q000473:pathology / Q000652:urine*; D004789:Enzyme Activation; D005956:Glucose-6-Phosphate Isomerase / Q000032:analysis*; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000473:pathology / Q000652:urine*
D015703:Antigens, CD; D000951:Antigens, Neoplasm; C497886:BSG protein, human; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; D051926:Basigin; D005956:Glucose-6-Phosphate Isomerase